OA13348A - Composition pharmaceutique de vinflunine destinée à une administration parentérale, procédé de préparation et utilisation. - Google Patents
Composition pharmaceutique de vinflunine destinée à une administration parentérale, procédé de préparation et utilisation. Download PDFInfo
- Publication number
- OA13348A OA13348A OA1200600208A OA1200600208A OA13348A OA 13348 A OA13348 A OA 13348A OA 1200600208 A OA1200600208 A OA 1200600208A OA 1200600208 A OA1200600208 A OA 1200600208A OA 13348 A OA13348 A OA 13348A
- Authority
- OA
- OAPI
- Prior art keywords
- composition according
- vinflunine
- vinilunine
- ditartrate
- water
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4375—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having nitrogen as a ring heteroatom, e.g. quinolizines, naphthyridines, berberine, vincamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/475—Quinolines; Isoquinolines having an indole ring, e.g. yohimbine, reserpine, strychnine, vinblastine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Dermatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0315312A FR2863891B1 (fr) | 2003-12-23 | 2003-12-23 | Composition pharmaceutique de vinflunine destinee a une administration parentale, procede de preparation et utilisation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| OA13348A true OA13348A (fr) | 2007-04-13 |
Family
ID=34630533
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| OA1200600208A OA13348A (fr) | 2003-12-23 | 2004-12-17 | Composition pharmaceutique de vinflunine destinée à une administration parentérale, procédé de préparation et utilisation. |
Country Status (35)
| Country | Link |
|---|---|
| US (1) | US20070155768A1 (es) |
| EP (1) | EP1696913B1 (es) |
| JP (2) | JP5226220B2 (es) |
| KR (1) | KR101166347B1 (es) |
| CN (2) | CN1897940A (es) |
| AR (1) | AR047346A1 (es) |
| AT (1) | ATE424201T1 (es) |
| AU (1) | AU2004314154B2 (es) |
| BR (1) | BRPI0418005B8 (es) |
| CA (1) | CA2551493C (es) |
| CR (1) | CR8473A (es) |
| CY (1) | CY1109120T1 (es) |
| DE (1) | DE602004019809D1 (es) |
| DK (1) | DK1696913T3 (es) |
| EC (1) | ECSP066663A (es) |
| ES (1) | ES2323374T3 (es) |
| FR (1) | FR2863891B1 (es) |
| HK (1) | HK1089105A1 (es) |
| IL (1) | IL176404A (es) |
| MA (1) | MA28237A1 (es) |
| MX (1) | MXPA06007208A (es) |
| MY (1) | MY139643A (es) |
| NI (1) | NI200600146A (es) |
| NO (1) | NO336427B1 (es) |
| NZ (1) | NZ548028A (es) |
| OA (1) | OA13348A (es) |
| PL (1) | PL1696913T3 (es) |
| PT (1) | PT1696913E (es) |
| RU (1) | RU2362557C2 (es) |
| SI (1) | SI1696913T1 (es) |
| TN (1) | TNSN06197A1 (es) |
| TW (1) | TWI334352B (es) |
| UA (1) | UA83888C2 (es) |
| WO (1) | WO2005070425A1 (es) |
| ZA (1) | ZA200605201B (es) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20110015221A1 (en) * | 2003-12-23 | 2011-01-20 | Pierre Fabre Medicament | Pharmaceutical composition of vinflunine which is intended for parenteral administration preparation method thereof and use of same |
| FR2863891B1 (fr) * | 2003-12-23 | 2006-03-24 | Pf Medicament | Composition pharmaceutique de vinflunine destinee a une administration parentale, procede de preparation et utilisation |
| FR2910812B1 (fr) | 2006-12-29 | 2009-03-20 | Pierre Fabre Medicament Sa | Compositions pharmaceutiques injectables lyophilisees de derives hemi-synthetiques d'alcaloide de vinca stables a temperature ambiante |
| FR2912406B1 (fr) * | 2007-02-13 | 2009-05-08 | Pierre Fabre Medicament Sa | Sels cristalins anhydres de vinflunine, procede de preparation et utilisation en tant que medicament et moyen de purification de la vinflunine. |
| EP1997534A1 (en) * | 2007-05-31 | 2008-12-03 | Pierre Fabre Medicament | Cancer treatment combination therapy comprising vinflunine and trastuzumab |
| CN101129374B (zh) * | 2007-06-26 | 2010-09-08 | 齐鲁制药有限公司 | 长春氟宁药物组合物及其制备方法与应用 |
| FR2918567B1 (fr) * | 2007-07-11 | 2012-08-03 | Pf Medicament | Composition pharmaceutique stable d'un sel hydrosoluble de vinorelbine. |
| FR2918566B1 (fr) * | 2007-07-11 | 2009-10-09 | Pierre Fabre Medicament Sa | Composition pharmaceutique stable d'un sel hydrosoluble de vinflunine. |
| CN101607968A (zh) * | 2008-06-17 | 2009-12-23 | 江苏豪森药业股份有限公司 | 长春氟宁盐、其制备方法及其药物组合物 |
| UY33975A (es) * | 2011-03-29 | 2012-10-31 | Sanofi Sa | Formulaciones de otamixaban con estabilidad mejorada |
| EP3777861A1 (en) * | 2015-08-01 | 2021-02-17 | Sun Pharmaceutical Industries Ltd | Dosage form of vinca alkaloid drug |
| WO2018007554A1 (en) * | 2016-07-06 | 2018-01-11 | Pierre Fabre Medicament | Vinflunine and pd1 and/or pdl1 inhibitor as pharmaceutical combination |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4307100A (en) * | 1978-08-24 | 1981-12-22 | Agence Nationale De Valorisation De La Recherche (Anvar) | Nor bis-indole compounds usable as medicaments |
| US4619935A (en) * | 1983-03-17 | 1986-10-28 | Eli Lilly And Company | Stable oncolytic formulations |
| HU195513B (en) * | 1984-10-16 | 1988-05-30 | Richter Gedeon Vegyeszet | Process for producing stable solutions of alkaloides with bis-indole skeleton |
| FR2597750B1 (fr) * | 1986-04-25 | 1989-06-02 | Pf Medicament | Solution aqueuse stable de sulfate de vincristine |
| IL83086A (en) * | 1987-07-06 | 1991-03-10 | Teva Pharma | Stable,injectable solutions of vincristine salts |
| US4923876A (en) * | 1988-04-18 | 1990-05-08 | Cetus Corporation | Vinca alkaloid pharmaceutical compositions |
| CA2001643A1 (en) * | 1988-12-23 | 1990-06-23 | Richard L. Wolgemuth | Preservative-free multi-dose vincristine solution |
| HU204995B (en) * | 1989-11-07 | 1992-03-30 | Richter Gedeon Vegyeszet | Process for producing pharmaceutical composition comprising alkaloid with bis-indole skeleton, with antitumour activity and suitable fr parenteral purposes |
| JPH06100452A (ja) * | 1993-04-06 | 1994-04-12 | Asta Medica Ag | イホスファミド用の製薬学的容器 |
| FR2707988B1 (fr) * | 1993-07-21 | 1995-10-13 | Pf Medicament | Nouveaux dérivés antimitotiques des alcaloïdes binaires du catharantus rosesus, leur procédé de préparation et les compositions pharmaceutiques les comprenant. |
| DE19706255C2 (de) * | 1997-02-18 | 2000-11-30 | Schott Glas | Sterilisierbarer Glasbehälter für medizinische Zwecke, insbesondere zur Aufbewahrung pharmazeutischer oder diagnostischer Produkte |
| FR2761990B1 (fr) * | 1997-04-10 | 1999-06-25 | Pf Medicament | Derives halogenes antimitotiques d'alcaloides de vinca |
| JP3642492B1 (ja) * | 2003-10-31 | 2005-04-27 | 小野薬品工業株式会社 | オザグレルナトリウム含有水溶液を充填してなる注射用容器 |
| FR2863891B1 (fr) * | 2003-12-23 | 2006-03-24 | Pf Medicament | Composition pharmaceutique de vinflunine destinee a une administration parentale, procede de preparation et utilisation |
-
2003
- 2003-12-23 FR FR0315312A patent/FR2863891B1/fr not_active Expired - Lifetime
-
2004
- 2004-12-17 SI SI200431131T patent/SI1696913T1/sl unknown
- 2004-12-17 CA CA2551493A patent/CA2551493C/fr active Active
- 2004-12-17 AT AT04816422T patent/ATE424201T1/de active
- 2004-12-17 DK DK04816422T patent/DK1696913T3/da active
- 2004-12-17 DE DE602004019809T patent/DE602004019809D1/de active Active
- 2004-12-17 OA OA1200600208A patent/OA13348A/fr unknown
- 2004-12-17 KR KR1020067011520A patent/KR101166347B1/ko active IP Right Grant
- 2004-12-17 UA UAA200608219A patent/UA83888C2/ru unknown
- 2004-12-17 CN CNA2004800380077A patent/CN1897940A/zh active Pending
- 2004-12-17 CN CN200910169123A patent/CN101695474A/zh active Pending
- 2004-12-17 RU RU2006126708/15A patent/RU2362557C2/ru active Protection Beyond IP Right Term
- 2004-12-17 US US10/584,445 patent/US20070155768A1/en not_active Abandoned
- 2004-12-17 EP EP04816422A patent/EP1696913B1/fr active Active
- 2004-12-17 NZ NZ548028A patent/NZ548028A/en unknown
- 2004-12-17 JP JP2006546235A patent/JP5226220B2/ja active Active
- 2004-12-17 PL PL04816422T patent/PL1696913T3/pl unknown
- 2004-12-17 ES ES04816422T patent/ES2323374T3/es active Active
- 2004-12-17 WO PCT/FR2004/003287 patent/WO2005070425A1/fr active Application Filing
- 2004-12-17 MX MXPA06007208A patent/MXPA06007208A/es active IP Right Grant
- 2004-12-17 BR BRPI0418005A patent/BRPI0418005B8/pt active IP Right Grant
- 2004-12-17 PT PT04816422T patent/PT1696913E/pt unknown
- 2004-12-17 AU AU2004314154A patent/AU2004314154B2/en active Active
- 2004-12-22 TW TW093139925A patent/TWI334352B/zh active
- 2004-12-22 AR ARP040104869A patent/AR047346A1/es unknown
- 2004-12-23 MY MYPI20045331A patent/MY139643A/en unknown
-
2006
- 2006-02-21 CR CR8473A patent/CR8473A/es unknown
- 2006-06-19 IL IL176404A patent/IL176404A/en active Protection Beyond IP Right Term
- 2006-06-21 EC EC2006006663A patent/ECSP066663A/es unknown
- 2006-06-22 TN TNP2006000197A patent/TNSN06197A1/fr unknown
- 2006-06-22 MA MA29124A patent/MA28237A1/fr unknown
- 2006-06-23 ZA ZA200605201A patent/ZA200605201B/en unknown
- 2006-06-23 NI NI200600146A patent/NI200600146A/es unknown
- 2006-07-14 NO NO20063277A patent/NO336427B1/no unknown
- 2006-09-15 HK HK06110282.0A patent/HK1089105A1/xx unknown
-
2009
- 2009-06-03 CY CY20091100590T patent/CY1109120T1/el unknown
-
2011
- 2011-12-26 JP JP2011283976A patent/JP5710462B2/ja active Active
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP5710462B2 (ja) | 非経口投与を目的とするビンフルニンの医薬組成物、その調製方法およびその使用 | |
| CA2468916C (en) | A stable oxaliplatin solution formulation | |
| FR2853547A1 (fr) | Compositions pharmaceutiques injectables contenant de la piperacilline et du tazobactame, et procede pour leur production | |
| CN108135980B (zh) | 在非质子极性溶剂中制备稳定的胰高血糖素治疗制剂的方法 | |
| EP1207875B1 (fr) | Preparation pharmaceutique stable d'oxaliplatine pour administration par voie parenterale | |
| US20180369383A1 (en) | Formulations of bendamustine | |
| WO2013179310A1 (en) | Stable aqueous compositions of pemetrexed | |
| CN1396828A (zh) | 含有培美西德以及一硫代甘油l－半胱氨酸或巯乙酸的药物组合物 | |
| FR2910812A1 (fr) | Compositions pharmaceutiques injectables lyophilisees de derives hemi-synthetiques d'alcaloide de vinca stables a temperature ambiante | |
| US20110015221A1 (en) | Pharmaceutical composition of vinflunine which is intended for parenteral administration preparation method thereof and use of same | |
| WO2023072714A1 (en) | Phytonadione for parenteral administration | |
| CZ200749A3 (cs) | Sterilní kapalná farmaceutická kompozice a zpusobjejí výroby | |
| CA3109440A1 (en) | Stable ready-to-use carmustine pharmaceutical composition |